A LARP1::MRPL22 fusion has been reported to be recurrently expressed in B-cell non-Hodgkin lymphoma; however, its clinical significance remains unclear [8,9]. This evidence concerns the gene MRPL22 and B-cell non-Hodgkin lymphoma.